5&agr;-Reductase inhibitors in androgenetic alopecia

@article{Yim20145agrReductaseII,
  title={5&agr;-Reductase inhibitors in androgenetic alopecia},
  author={Elizabeth Yim and K. L. B. Nole and A. Tosti},
  journal={Current Opinion in Endocrinology & Diabetes and Obesity},
  year={2014},
  volume={21},
  pages={493–498}
}
  • Elizabeth Yim, K. L. B. Nole, A. Tosti
  • Published 2014
  • Medicine
  • Current Opinion in Endocrinology & Diabetes and Obesity
  • Purpose of reviewThe authors will review the current literature on efficacy and safety of 5-alpha reductase inhibitors (5&agr;RIs) for androgenetic alopecia (AGA). Recent findingsThe 5&agr;RI finasteride and dutasteride are effective in treating AGA and promoting hair regrowth. 5&agr;RI can be given orally, topically and more recently through mesotherapy. However, there has been an increasing concern about permanent sexual adverse events such as impotence and infertility. Most of these reports… CONTINUE READING
    25 Citations
    Safety concerns when using novel medications to treat alopecia
    • 8
    Finasteride adverse effects and post-finasteride syndrome; implications for dentists
    • 8
    Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
    • 56
    Treatments options for alopecia
    • 16
    Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs.

    References

    SHOWING 1-10 OF 78 REFERENCES
    Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
    • 148
    Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    • 217
    Comparative Efficacy of Various Treatment Regimens for Androgenetic Alopecia in Men
    • 71